Paragon Partners sells inprotec AG to International Chemical Investors Group
Heitersheim/ Munich — Paragon Partners and the minority shareholders sell 100% of the shares in inprotec to International Chemical Investors Group. The transaction is still subject to approval by the relevant antitrust authorities.
Based in Heitersheim, Baden-Württemberg, inprotec AG is a leading service provider for industrial contract drying and granulation based on spray drying, spray granulation, fluid bed coating as well as matrix encapsulation. Paragon acquired a majority stake in inprotec in 2018 and has since invested more than €20 million in expanding its production facilities. During the past four years, inprotec has significantly expanded its market position as a technology leader in large-volume granulation and drying processes, further broadened its customer base, and achieved profitable business development with double-digit annual growth rates.
Based on the special strengths of the company, the current management will continue the successful corporate development of inprotec within the ICIG network with ICIG as a future partner.
About Paragon Partners
Paragon Partners is an owner-managed investment company and has been investing in medium-sized companies in German-speaking countries since its foundation in 2004. The investment portfolio spans various industries and currently comprises 14 companies. Currently, Paragon manages more than €1.2 billion in equity. www.paragon.de
International Chemical Investors Group is a privately owned industrial group with total sales of €4 billion. ICIG focuses on three main platforms: Fine Chemicals under the WeylChem brand, Chlorovinyls under the Vynova brand, and Enterprises with specialized companies in fermentation products, viscose filaments, activated carbon and wood preservation chemicals (including “Corden BioChem”, “ENKA”, “CarboTech” and “Rütgers Organics”). Since its founding in 2004, ICIG has grown to include more than 20 independent chemical companies, all of which have their origins in large global chemical or pharmaceutical groups. Today, the ICIG companies employ around 4,500 people and operate more than 20 production sites in Europe and the United States. Additional information can be found at www.ic-investors.com.
Clifford Chance advised Paragon Partners and the minority shareholders on the sale of 100% of the shares in inprotec to International Chemical Investors Group.
The Clifford Chance team was led by partner Dr. Mark Aschenbrenner (Corporate/Private Equity, Munich).